Antibody-drug conjugates or ADCs are a class of biopharmaceutical drugs designed as a targeted therapy for treating cancer. Biopharma PEG (Biochempeg) is dedicated to being your most reliable partner to provide high-quality PEG linkers to promote the progress of your ADC R&D. PEG Linker is one of the most widely used linkers in ADCs, which can increase the water solubility, improve the DAR value and increase the cycle half-life of ADCs. Website: https://www.biochempeg.com/
BiopharmaCancer ResearchChemistryDrug Discovery